Russia
· Delayed Price · Currency is RUB Pharmacy Chain 36.6 Statistics
Total Valuation
Pharmacy Chain 36.6 has a market cap or net worth of RUB 95.35 billion. The enterprise value is 124.73 billion.
| Market Cap | 95.35B |
| Enterprise Value | 124.73B |
Important Dates
The next estimated earnings date is Friday, April 25, 2025.
| Earnings Date | Apr 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Pharmacy Chain 36.6 has 7.63 billion shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 7.63B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 11.49% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.58 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.76, with an EV/FCF ratio of 14.10.
| EV / Earnings | -746.90 |
| EV / Sales | 2.07 |
| EV / EBITDA | 12.76 |
| EV / EBIT | 29.59 |
| EV / FCF | 14.10 |
Financial Position
The company has a current ratio of 0.52
| Current Ratio | 0.52 |
| Quick Ratio | 0.17 |
| Debt / Equity | n/a |
| Debt / EBITDA | 3.39 |
| Debt / FCF | 3.75 |
| Interest Coverage | 1.02 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.98% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -7.98% |
| 50-Day Moving Average | 12.48 |
| 200-Day Moving Average | 13.15 |
| Relative Strength Index (RSI) | 54.61 |
| Average Volume (20 Days) | 491,805 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Pharmacy Chain 36.6 had revenue of RUB 60.35 billion and -167.00 million in losses. Loss per share was -0.02.
| Revenue | 60.35B |
| Gross Profit | 20.06B |
| Operating Income | 4.22B |
| Pretax Income | -234.00M |
| Net Income | -167.00M |
| EBITDA | 5.66B |
| EBIT | 4.22B |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 521.00 million in cash and 33.15 billion in debt, giving a net cash position of -32.63 billion or -4.28 per share.
| Cash & Cash Equivalents | 521.00M |
| Total Debt | 33.15B |
| Net Cash | -32.63B |
| Net Cash Per Share | -4.28 |
| Equity (Book Value) | -6.64B |
| Book Value Per Share | -0.87 |
| Working Capital | -12.56B |
Cash Flow
In the last 12 months, operating cash flow was 9.57 billion and capital expenditures -721.00 million, giving a free cash flow of 8.84 billion.
| Operating Cash Flow | 9.57B |
| Capital Expenditures | -721.00M |
| Free Cash Flow | 8.84B |
| FCF Per Share | 1.16 |
Margins
Gross margin is 33.23%, with operating and profit margins of 6.99% and -0.28%.
| Gross Margin | 33.23% |
| Operating Margin | 6.99% |
| Pretax Margin | -0.39% |
| Profit Margin | -0.28% |
| EBITDA Margin | 9.39% |
| EBIT Margin | 6.99% |
| FCF Margin | 14.65% |
Dividends & Yields
Pharmacy Chain 36.6 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.01% |
| Shareholder Yield | 0.01% |
| Earnings Yield | -0.18% |
| FCF Yield | 9.28% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Pharmacy Chain 36.6 has an Altman Z-Score of 0.7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.7 |
| Piotroski F-Score | n/a |